Cargando…

Microglia Polarization in Alzheimer’s Disease: Mechanisms and a Potential Therapeutic Target

Neuroinflammation regulated by microglia is one of the important factors involved in the pathogenesis of Alzheimer’s disease (AD). Activated microglia exhibited phenotypes termed as M1 and M2 phenotypes separately. M1 microglia contribute to the development of inflammation via upregulating pro-infla...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Qinqin, Yao, Hongmei, Liu, Wenyan, Ya, Bailiu, Cheng, Hongju, Xing, Zhenkai, Wu, Yili
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Aging Neuroscience
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8606412/ https://www.ncbi.nlm.nih.gov/pubmed/34819850 http://dx.doi.org/10.3389/fnagi.2021.772717

Ejemplares similares

Blood-brain barrier dysfunction and Alzheimer’s disease: associations, pathogenic mechanisms, and therapeutic potential
por: Chen, Yanting, et al.
Publicado: (2023)

Functional and Phenotypic Diversity of Microglia: Implication for Microglia-Based Therapies for Alzheimer’s Disease
por: Xu, Yi-Jun, et al.
Publicado: (2022)

Emerging Alzheimer’s disease therapeutics: promising insights from lipid metabolism and microglia-focused interventions
por: Tobeh, Nour S., et al.
Publicado: (2023)

Contribution of “Genuine Microglia” to Alzheimer's Disease Pathology
por: Hashioka, Sadayuki, et al.
Publicado: (2022)

Microglia Polarization From M1 to M2 in Neurodegenerative Diseases
por: Guo, Shenrui, et al.
Publicado: (2022)

Neuronal ApoE4 in Alzheimer’s disease and potential therapeutic targets
por: Zhang, Lan, et al.
Publicado: (2023)

Platelet Activating Factor Receptor Exaggerates Microglia-Mediated Microenvironment by IL10-STAT3 Signaling: A Novel Potential Biomarker and Target for Diagnosis and Treatment of Alzheimer’s Disease
por: Liu, Junxiu, et al.
Publicado: (2022)

The Role of Microglia in Alzheimer’s Disease From the Perspective of Immune Inflammation and Iron Metabolism
por: Long, Hui-Zhi, et al.
Publicado: (2022)

Editorial: Expert opinions on the relationship between microglia, glia, and Alzheimer's disease: 2022
por: Gomez-Arboledas, Angela, et al.
Publicado: (2023)

Corrigendum: The Potential of Ferroptosis-Targeting Therapies for Alzheimer's Disease: From Mechanism to Transcriptomic Analysis
por: Majerníková, Nad'a, et al.
Publicado: (2022)

Microglia in Alzheimer’s disease: pathogenesis, mechanisms, and therapeutic potentials
por: Miao, Jifei, et al.
Publicado: (2023)

Mitochondria-associated membranes (MAMs): a potential therapeutic target for treating Alzheimer’s disease
por: Yu, Weiwei, et al.
Publicado: (2021)

The NLRP3 inflammasome is a potential mechanism and therapeutic target for perioperative neurocognitive disorders
por: Li, Jiayue, et al.
Publicado: (2023)

Editorial: Novel mechanisms involved in aging and neurodegeneration: Seeking potential therapeutic targets for neurodegenerative diseases
por: Sanhueza, Mario, et al.
Publicado: (2022)

The Role of Microglia in Perioperative Neuroinflammation and Neurocognitive Disorders
por: Saxena, Sarah, et al.
Publicado: (2021)

The Interplay Between Brain Vascular Calcification and Microglia
por: Maheshwari, Upasana, et al.
Publicado: (2022)

Editorial: The role of microglia in the pathogenesis of neurodegenerative diseases
por: Qin, Qi, et al.
Publicado: (2023)

Editorial: Alzheimer-related affective symptoms – mechanism and treatment
por: Nitzan, Keren, et al.
Publicado: (2023)

Clinical PET Imaging of Microglial Activation: Implications for Microglial Therapeutics in Alzheimer’s Disease
por: Shen, Zhiwei, et al.
Publicado: (2018)

Editorial: Role of microglia autophagy in age-related neurodegenerative diseases
por: Wang, Zihua
Publicado: (2023)

A Review of ApoE4 Interference Targeting Mitophagy Molecular Pathways for Alzheimer's Disease
por: Chen, Huiyi, et al.
Publicado: (2022)

Targets and mechanisms of Alpinia oxyphylla Miquel fruits in treating neurodegenerative dementia
por: Zeng, Peng, et al.
Publicado: (2022)

The dual face of microglia (M1/M2) as a potential target in the protective effect of nutraceuticals against neurodegenerative diseases
por: Darwish, Samar F., et al.
Publicado: (2023)

Editorial: The Neurovascular Unit as a Potential Biomarker and Therapeutic Target in Cerebrovascular Disease
por: Nizari, Shereen, et al.
Publicado: (2022)

Phosphorylated Tau 181 Serum Levels Predict Alzheimer’s Disease in the Preclinical Stage
por: Qin, Wei, et al.
Publicado: (2022)

Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer’s disease
por: Shade, Ronnie D., et al.
Publicado: (2022)

Editorial: Disease-modifying targets and strategies for Alzheimer's disease and Parkinson's disease
por: Gao, Xiaoya
Publicado: (2023)

Microglia in Alzheimer’s Disease: A Target for Therapeutic Intervention
por: Zhang, Guimei, et al.
Publicado: (2021)

A Network Pharmacology Based Research on the Mechanism of Donepezil in Treating Alzheimer's Disease
por: Liu, Lihua, et al.
Publicado: (2022)

The therapeutic efficacy of transcranial magnetic stimulation in managing Alzheimer’s disease: A systemic review and meta-analysis
por: Wei, Zhenyu, et al.
Publicado: (2022)

Salidroside Ameliorates Alzheimer's Disease by Targeting NLRP3 Inflammasome-Mediated Pyroptosis
por: Cai, Yawen, et al.
Publicado: (2022)

Small-molecule drugs development for Alzheimer's disease
por: Yao, Weiwei, et al.
Publicado: (2022)

c-Abl tyrosine kinase down-regulation as target for memory improvement in Alzheimer’s disease
por: León, Rilda, et al.
Publicado: (2023)

QbD-based rivastigmine tartrate-loaded solid lipid nanoparticles for enhanced intranasal delivery to the brain for Alzheimer's therapeutics
por: Arora, Deepshi, et al.
Publicado: (2022)

Network Pharmacology-Based Strategy to Investigate the Pharmacologic Mechanisms of Coptidis Rhizoma for the Treatment of Alzheimer's Disease
por: Ye, Xian-wen, et al.
Publicado: (2022)

Integration of network pharmacology and molecular docking to explore the molecular mechanism of Cordycepin in the treatment of Alzheimer’s disease
por: Ma, Xiaoying, et al.
Publicado: (2022)

Editorial: The crosstalk of different mechanisms in cognitive impairment associated with aging, Alzheimer's disease, and related dementias
por: Giménez-Llort, Lydia
Publicado: (2023)

The role of APOE4 in Alzheimer’s disease: strategies for future therapeutic interventions
por: Hunsberger, Holly C., et al.
Publicado: (2019)

A Spatiotemporal Brain Network Analysis of Alzheimer’s Disease Based on Persistent Homology
por: Xing, Jiacheng, et al.
Publicado: (2022)

Identification and immunological characterization of cuproptosis-related molecular clusters in Alzheimer's disease
por: Lai, Yongxing, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_0s9ddp2bokkoe5hv5dkuaoq1ha